Long-term treatment of psychotic (delusional) depression with fluvoxamine: An open pilot study

International Clinical Psychopharmacology

Volumn 12, Issue 4, 1997, Pages 195-197

  Zanardi, R ^a   Franchini, L ^a   Gasperini, M ^a   Smeraldi, E ^a   Perez, J ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Continuation treatment; Fluvoxamine; Maintenance treatment; Psychotic (delusional) depression

Indexed keywords

FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DELUSION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MAJOR DEPRESSION; MALE; MANIC DEPRESSIVE PSYCHOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 0030829073     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199707000-00002     Document Type: Article

References (17)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition (DSM-IV). American Psychiatric Association, Washington.
2. Belsher G and Costello CG (1988) Relapse after recovery from unipolar depression: a critical review. Psychological Bulletin, 104, 84-96.
3. Franchini L, Gasperini M, Perez J, Smeraldi E and Zanardi R (1997) A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression. Journal of Clinical Psychiatry, 58, 104-107.
4. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB and Grochocinski VJ (1990) Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093-1099.
5. Gatti F, Bellini L, Gasperini M, Perez J, Zanardi R and Smeraldi E (1996) Fluvoxamine alone in the treatment of delusional depression. American Journal of Psychiatry, 153, 414-416.
6. Glassman AH and Roose SP (1981) Delusional depression: a distinct clinical entity? Archives of General Psychiatry, 38, 424-427.
7. Keller MB, Lavori PW, Lewis CE and Klerman GL (1983) Predictors of relapse in major depressive disorders. Journal of the American Medical Association, 250, 3299-3304.
8. Kupfer DJ, Perel JM and Frank EL (1989) Adequate treatment with imipramine in continuation treatment. Journal of Clinical Psychiatry, 50, 250-255.
9. Montgomery SA, Dufour H, Brion S, Gailledreau J, Laqueille X, Ferrey G, Moron P, Parant-Lucena N, Singer L, Danion JM et al. (1988) The prophylactic efficacy of fluoxetine in unipolar depression. British Journal of Psychiatry, 153, 69-76.
10. Montgomery SA, Doogan DP and Burnside R (1991) The influence of different relapse criteria on the assessment of long-term efficacy of sertraline. International Clinical Psychopharmacology, 6 (Suppl 2), 37-46.
11. Montgomery SA (1994) Long-term treatment of depression. British Journal of Psychiatry, 165 (Suppl 26), 31-36.
12. Parker G, Roy K, Hadzi-Pavlovic D and Pedic F (1992) Psychotic (delusional) depression: a meta-analysis of physical treatments. Journal of Affective Disorders, 24, 17-24.
13. Prien RF and Kocsis JH (1995) Long-term treatment of mood disorders. In: Psychopharmacology: The fourth Generation of Progress (Eds FE Bloom and DJ Kupfer), pp. 1067-1080. Raven Press, New York.
14. Schatzberg AF and Rothschild AJ (1992) Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? American Journal of Psychiatry, 149, 733-745.
15. Smeraldi E, Cavallaro R, Di Rosa M, Della Maggiore P and Brancato V (1991) Prevalence and risk factors of involuntary movement disorders in neuroleptic-treated population: a comparison between schizophrenic spectrum and non-schizophrenic spectrum patients. Schizophrenia Research, 4, 367-368.
16. Rothschild AJ (1996) Management of psychotic, treatment-resistant depression. The Psychiatric Clinics of North America, 19, 237-252.
17. Zanardi R, Franchini L, Gasperini M, Perez J and Smeraldi E (1996) Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. American Journal of Psychiatry, 153, 1631-1633.